Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Licensing opportunity from NIH: method of inducing increased resistance to stroke

Sep. 8, 1998

CP-154526, a CRF1 receptor antagonist, reduces stress-induced relapse of drug use in rats

Sep. 8, 1998

Lilly and Synaptic enter late-stage trials with antimigraine agent

Sep. 7, 1998

DMP-695: ACS debut for new, orally active CRF1 antagonist

Sep. 7, 1998

Potent, orally active, second-generation neuroimmunophilin from Guilford

Sep. 7, 1998

Maruishi licenses rights to Chirocaine in Japan

Sep. 7, 1998

Potent mixed delta/mu-opioid agonist identified by Glaxo Wellcome/Delta team

Sep. 4, 1998

Taisho discovers potent and selective CRF1 receptor antagonists with anxiolytic effects

Sep. 4, 1998

P&U, U of Maryland describe inhibitors of kynurenine aminotransferase

Sep. 4, 1998

Neuroprotective and antioxidant phenazines designed at Nippon Chemiphar

Sep. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...